secwatch.observer — SEC 8-K summary
======================================

Issuer:     HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK:        0000818033
Form:       8-K
Filed at:   2024-06-18T23:59:59+00:00
Accession:  0000950170-24-074952
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heron shareholders approve increase in authorized shares to 400M and equity plan share expansion
--------------------------------------------------------------------------------

- Authorized common stock increased by 175M shares from 225M to 400M; effective June 13, 2024.
- 2007 Plan shares increased by 7.5M (from 39.19M to 46.69M) and ESPP shares by 1.2M (from 2.225M to 3.425M).
- All six director nominees elected with ~87M votes for each; auditor ratified with ~114M votes for.
- Say-on-pay advisory vote passed with 72.7M for vs 14.4M against; broker non-votes of 29.2M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818033/000095017024074952/0000950170-24-074952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818033/000095017024074952/hrtx-20240613.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-074952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer